This week the Centers for Medicare and Medicaid Services did something Washington rarely manages: it drew a line and held it. The agency finalized a rule pulling federal Medicaid and CHIP dollars out of what it calls “sex-rejecting procedures” for minors: puberty blockers, cross-sex hormones, and the surgeries that go with them. It takes effect October 13. The professional outrage machine fired up within hours, right on schedule. I'd like to offer a different reaction. It's about time.

I've spent more than three decades managing other people's money and testifying as a court-designated expert on fiduciary duty. My job, boiled down, is answering one question: who bears the risk, and did that person actually consent to it? A Twelve-year-old can't take out a mortgage, enlist, buy a beer, or get a tattoo in most states without a parent's signature. Yet for the better part of the decade, federal health entitlements have quietly underwritten irreversible interventions on that exact population, no fiduciary standard required, no informed-consent bar remotely comparable to what I'd need to clear before putting a client into a risky private placement.

Let's be precise about what the rule actually does, because a lot of the coverage hasn't been. It bans nothing. States remain free to fund these treatments with their own money if they choose. CMS isn't raiding hospitals or handcuffing physicians. It's withdrawing the federal match. Roughly 17 state Medicaid programs currently cover one or more of these interventions for minors, and those states now face a choice: pay for it themselves or stop. Mental health coverage for kids with gender dysphoria stays fully intact. Anyone........

© Townhall